Chronic respiratory diseases account for more than 315,000 Europeans dying every year. Diseases such as respiratory allergy, asthma and COPD cost more than €300 billion to Europe’s economy annually. How can we act to reduce the burden of these diseases on both patients and Europe’s health and long-term care systems?
24 January 2017 was the final day for MEPs to voice their support for further action on chronic respiratory diseases through the Written Declaration 115/2016. The Declaration collected 249 signatures, which means that 1 in 3 MEPs actively supported further action in the area.
Throughout the campaign European patients, doctors, public health and environmental advocates joined forces to seek the support of the European Parliament to embed a “health in all policies” approach at European level to improve respiratory health. Two successful events held throughout the campaign significantly increased focus on the topic. Read more about the event Act. Belive. Care. held in the European Parliament on 11 January by ENSP, EFA, ERS and EAACI below.
ENSP would like to thank all collaborating partners and ENSP members for their efforts during the campaign.
Act. Believe. Care. The ABC to lead actions on Chronic Respiratory Diseases
The event Act. Believe. Care. held in the European Parliament on 11 January 2017, provided a perfect forum for the panelists from EFA, EAACI, ENSP and ERS to flag policy actions to improve research, prevention and care of chronic respiratory diseases in Europe.
The full report of The ABC to lead actions on Chronic Respiratory Diseases event is available here.
The event served as the grand finale to our #BreatheMission campaign to ask Members of the European Parliament to take action against chronic respiratory diseases by signing the written declaration 115/2016 on chronic respiratory diseases.
The event sessions facilitated energetic and participatory discussions providing a range of perspectives on the importance of taking care of the respiratory health of European citizens, and how we can work to tackle the issue and improve treatment and care for patients.
Co-hosted by MEP Karin Kadenbach, S&D, Austria and MEP Sirpa Pietikäinen, EPP, Finland
Mikaela Odemyr, EFA
Prof. John Wright, London School of Economics and Political Sciences
Andrzej Rys, European Commission (TBC)
Antonella Muraro, EAACI European Academy of Allergy and Clinical Immunology (TBC)
Guy Joos, ERS European Respiratory Society
Cornel Radu-Loghin, ENSP European Network for Smoking and Tobacco Prevention